CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -98.4% | 341 | -98.3% | 0.00% | – |
Q1 2022 | $64,000 | -23.8% | 20,141 | 0.0% | 0.00% | – |
Q4 2021 | $84,000 | -48.8% | 20,141 | -0.3% | 0.00% | – |
Q3 2021 | $164,000 | -31.7% | 20,209 | -36.3% | 0.00% | – |
Q2 2021 | $240,000 | -12.1% | 31,747 | +1.1% | 0.00% | – |
Q1 2021 | $273,000 | -8.4% | 31,400 | -16.0% | 0.00% | – |
Q4 2020 | $298,000 | +44.7% | 37,400 | +45.0% | 0.00% | – |
Q3 2020 | $206,000 | -19.2% | 25,800 | 0.0% | 0.00% | – |
Q2 2020 | $255,000 | +28.1% | 25,800 | 0.0% | 0.00% | – |
Q1 2020 | $199,000 | +101.0% | 25,800 | 0.0% | 0.00% | – |
Q4 2019 | $99,000 | -36.9% | 25,800 | -17.6% | 0.00% | – |
Q3 2019 | $157,000 | +35.3% | 31,300 | +77.8% | 0.00% | – |
Q2 2019 | $116,000 | -51.5% | 17,600 | -44.3% | 0.00% | – |
Q1 2019 | $239,000 | -6.3% | 31,600 | 0.0% | 0.00% | – |
Q4 2018 | $255,000 | -37.5% | 31,600 | 0.0% | 0.00% | – |
Q3 2018 | $408,000 | +13.3% | 31,600 | 0.0% | 0.00% | – |
Q2 2018 | $360,000 | – | 31,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |